Synapse - MSK Grad Students

Results (734)

Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)

Meeting Abstract

Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
Blood (2013)

Fulltext@MSK | Save

The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS

Meeting Abstract

Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
Blood (2013)

Fulltext@MSK | Save

High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation

Meeting Abstract

Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)

Meeting Abstract

Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
Blood (2013)

Fulltext@MSK | Save

Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute GVHD without increased toxicity in double-unit cord blood transplantation (CBT) recipients

Meeting Abstract

Harnicar, S. J.; Ponce, D. M.; Gregornik, D.; Mathew, S.; Evans, K. L.; Zheng, J.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; more...
Blood (2013)

Fulltext@MSK | Save

Prospective evaluation of alternative donor availability in 708 patients: Improved allograft access with enlarging CB inventory for all patients including racial and ethnic minorities

Meeting Abstract

Dahi, P. B.; Ponce, D. M.; Byam, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Gonzales, A. M. R.; Sideroff, M.; Wells, D.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save

T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)

Meeting Abstract

Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
Blood (2013)

Fulltext@MSK | Save

Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cell-selected PBSC results in 100% CB engraftment with enhanced myeloid recovery

Meeting Abstract

Barker, J. N.; Ponce, D. M.; Dahi, P. B.; Devlin, S.; Evans, K. L.; Lubin, M. N.; Meagher, R.; Reich, L.; Castro-Malaspina, H.; Goldberg, J. D.; more...
Blood (2013)

Fulltext@MSK | Save

Individual patient cancer profiles in the cBio Cancer Genomic Portal

Meeting Abstract

Gao, J. J.; Sumer, S. O.; Dresdner, G.; Aksoy, B. A.; Sander, C.; Schultz, N.
Cancer Research (2013)

Fulltext@MSK | Save

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer

Journal Article

Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save